Literature DB >> 2749110

Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire.

P H Sureau1.   

Abstract

About 5 weeks after the beginning of the outbreak of Ebola virus fever in Yambuku, Zaire, several acute cases of the disease were observed. All of those affected had the following common signs and symptoms: sudden onset of high fever, with chills, headache, myalgia, anorexia, nausea, abdominal pain, sore throat, expressionless face, and profound prostration. In some cases, on around the fifth day of the acute phase, the appearance of an exanthematous rash on the trunk announced the hemorrhagic manifestations: hemorrhagic conjunctivitis, bleeding ulcerations in the mouth and on the lips, gingival bleeding, hematemesis, and melena; epistaxis, ear bleeding, hematuria, and postpartum hemorrhages were also reported. All these hemorrhagic cases had a fatal outcome within about a week. The hemorrhagic manifestations were less severe in the cases that occurred by the end of the outbreak than in the first reported cases. Hemorrhagic manifestations were less frequent and less severe, or even absent, in the nonfatal cases (convalescents, serologically confirmed). No biologic investigation of the hemostatic impairment could be performed under the emergency conditions of this field study.

Entities:  

Mesh:

Year:  1989        PMID: 2749110     DOI: 10.1093/clinids/11.supplement_4.s790

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

Review 1.  Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection.

Authors:  Nisha Sharma; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

Review 2.  Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review.

Authors:  Gustavo E Velásquez; Omowunmi Aibana; Emilia J Ling; Ibrahim Diakite; Eric Q Mooring; Megan B Murray
Journal:  Clin Infect Dis       Date:  2015-06-30       Impact factor: 9.079

3.  Neurological Complications and Sequelae of Ebola Virus Disease.

Authors:  Bridgette Jeanne Billioux
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.663

4.  Retinal and gingival hemorrhaging and chronic hyperglycemia.

Authors:  Philippe P Hujoel; Marni Stott-Miller
Journal:  Diabetes Care       Date:  2010-10-11       Impact factor: 19.112

Review 5.  Does this patient have Ebola virus disease?

Authors:  Pierre Tattevin; Emanuele Durante-Mangoni; Moses Massaquoi
Journal:  Intensive Care Med       Date:  2014-09-03       Impact factor: 41.787

Review 6.  The Baboon (Papio spp.) as a model of human Ebola virus infection.

Authors:  Donna L Perry; Laura Bollinger; Gary L White
Journal:  Viruses       Date:  2012-10-23       Impact factor: 5.048

7.  Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.

Authors:  Paul Roddy; Natasha Howard; Maria D Van Kerkhove; Julius Lutwama; Joseph Wamala; Zabulon Yoti; Robert Colebunders; Pedro Pablo Palma; Esther Sterk; Benjamin Jeffs; Michel Van Herp; Matthias Borchert
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 8.  Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers.

Authors:  Victoria Wahl-Jensen; Laura Bollinger; David Safronetz; Fabian de Kok-Mercado; Dana P Scott; Hideki Ebihara
Journal:  Viruses       Date:  2012-12-14       Impact factor: 5.048

Review 9.  Ocular problem in Ebola virus infection: A short review.

Authors:  Somsri Wiwanitkit; Viroj Wiwanitkit
Journal:  Saudi J Ophthalmol       Date:  2015-03-06

10.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.

Authors:  Bruce Aylward; Philippe Barboza; Luke Bawo; Eric Bertherat; Pepe Bilivogui; Isobel Blake; Rick Brennan; Sylvie Briand; Jethro Magwati Chakauya; Kennedy Chitala; Roland M Conteh; Anne Cori; Alice Croisier; Jean-Marie Dangou; Boubacar Diallo; Christl A Donnelly; Christopher Dye; Tim Eckmanns; Neil M Ferguson; Pierre Formenty; Caroline Fuhrer; Keiji Fukuda; Tini Garske; Alex Gasasira; Stephen Gbanyan; Peter Graaff; Emmanuel Heleze; Amara Jambai; Thibaut Jombart; Francis Kasolo; Albert Mbule Kadiobo; Sakoba Keita; Daniel Kertesz; Moussa Koné; Chris Lane; Jered Markoff; Moses Massaquoi; Harriet Mills; John Mike Mulba; Emmanuel Musa; Joel Myhre; Abdusalam Nasidi; Eric Nilles; Pierre Nouvellet; Deo Nshimirimana; Isabelle Nuttall; Tolbert Nyenswah; Olushayo Olu; Scott Pendergast; William Perea; Jonathan Polonsky; Steven Riley; Olivier Ronveaux; Keita Sakoba; Ravi Santhana Gopala Krishnan; Mikiko Senga; Faisal Shuaib; Maria D Van Kerkhove; Rui Vaz; Niluka Wijekoon Kannangarage; Zabulon Yoti
Journal:  N Engl J Med       Date:  2014-09-22       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.